MoneyWorks4Me

Sun Pharma Laboratories informs about standalone financial results

26 May 2017 Evaluate

Sun Pharma Laboratories has informed about Standalone Financial Results & Auditors Report for the period ended March 31, 2017, and disclosure as per Regulation 52(4) & 52(5) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers